These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7881895)

  • 1. Double immunogold labelling demonstrating expression of recombinant genes for production of an anti-fertility vaccine.
    Mott MR; Reilly W
    Micron; 1994; 25(6):539-45. PubMed ID: 7881895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementation analysis of the Dichelobacter nodosus fimN, fimO, and fimP genes in Pseudomonas aeruginosa and transcriptional analysis of the fimNOP gene region.
    Johnston JL; Billington SJ; Haring V; Rood JI
    Infect Immun; 1998 Jan; 66(1):297-304. PubMed ID: 9423871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphogenetic expression of Bacteroides nodosus fimbriae in Pseudomonas aeruginosa.
    Mattick JS; Bills MM; Anderson BJ; Dalrymple B; Mott MR; Egerton JR
    J Bacteriol; 1987 Jan; 169(1):33-41. PubMed ID: 2878919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of sheep against footrot with a recombinant DNA-based fimbrial vaccine.
    Egerton JR; Cox PT; Anderson BJ; Kristo C; Norman M; Mattick JS
    Vet Microbiol; 1987 Sep; 14(4):393-409. PubMed ID: 2891214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional expression of heterologous type 4 fimbriae in Pseudomonas aeruginosa.
    Watson AA; Mattick JS; Alm RA
    Gene; 1996 Oct; 175(1-2):143-50. PubMed ID: 8917091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of pili from Bacteroides nodosus in Pseudomonas aeruginosa.
    Elleman TC; Hoyne PA; Stewart DJ; McKern NM; Peterson JE
    J Bacteriol; 1986 Nov; 168(2):574-80. PubMed ID: 2877967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-fimbriae of Escherichia coli as carriers for gonadotropin releasing hormone: development of a recombinant contraceptive vaccine.
    van der Zee A; Noordegraaf CV; van den Bosch H; Gielen J; Bergmans H; Hoekstra W; van Die I
    Vaccine; 1995; 13(8):753-8. PubMed ID: 7483791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy against footrot of a Bacteroides nodosus 265 (serogroup H) pilus vaccine expressed in Pseudomonas aeruginosa.
    Elleman TC; Stewart DJ
    Infect Immun; 1988 Mar; 56(3):595-600. PubMed ID: 2893772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Structural and functional specificity of the Dichelobacter nodosus pili. Synthesis of the protein pilin of D. nodosus in various bacterial recombinant strains].
    Zaberezhnyĭ AD; Grabovetskiĭ VV; Panasiuk SD; Alekseeva SV
    Mol Gen Mikrobiol Virusol; 2009; (4):3-6. PubMed ID: 20050159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and genetic mapping of proteins encoded in the fimbrial subunit gene region of Bacteroides nodosus.
    Billington SJ; Mitchison M; Adler B; Rood JI
    Vet Microbiol; 1990 Mar; 22(1):53-68. PubMed ID: 1970916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphogenetic expression of Moraxella bovis fimbriae (pili) in Pseudomonas aeruginosa.
    Beard MK; Mattick JS; Moore LJ; Mott MR; Marrs CF; Egerton JR
    J Bacteriol; 1990 May; 172(5):2601-7. PubMed ID: 1970564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning and expression in Escherichia coli of the gene encoding the structural subunit of Bacteroides nodosus fimbriae.
    Anderson BJ; Bills MM; Egerton JR; Mattick JS
    J Bacteriol; 1984 Nov; 160(2):748-54. PubMed ID: 6150025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of fimbriae from Bacteroides fragilis.
    van Doorn J; Mooi FR; Verweij-van Vught AM; MacLaren DM
    Microb Pathog; 1987 Aug; 3(2):87-95. PubMed ID: 2904638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective antibody titres and antigenic competition in multivalent Dichelobacter nodosus fimbrial vaccines using characterised rDNA antigens.
    Raadsma HW; O'Meara TJ; Egerton JR; Lehrbach PR; Schwartzkoff CL
    Vet Immunol Immunopathol; 1994 Mar; 40(3):253-74. PubMed ID: 7909183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular genetics of type-4 fimbriae in Pseudomonas aeruginosa--a review.
    Mattick JS; Whitchurch CB; Alm RA
    Gene; 1996 Nov; 179(1):147-55. PubMed ID: 8955641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type IV fimbrial biogenesis is required for protease secretion and natural transformation in Dichelobacter nodosus.
    Han X; Kennan RM; Parker D; Davies JK; Rood JI
    J Bacteriol; 2007 Jul; 189(14):5022-33. PubMed ID: 17513472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-LHRH and anti-pituitary gonadotropin vaccines: their development and clinical applications.
    Thau R
    Scand J Immunol Suppl; 1992; 11():127-30. PubMed ID: 1514027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fimbriae of Bacteroides nodosus: protein engineering of the structural subunit for the production of an exogenous peptide.
    Jennings PA; Bills MM; Irving DO; Mattick JS
    Protein Eng; 1989 Jan; 2(5):365-9. PubMed ID: 2564674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of recombinant ovalbumin-luteinizing hormone releasing hormone as a potential sterilization vaccine.
    Zhang Y; Rozell TG; deAvila DM; Bertrand KP; Reeves JJ
    Vaccine; 1999 Apr; 17(17):2185-91. PubMed ID: 10367953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-fertility vaccines.
    Talwar GP; Raghupathy R
    Vaccine; 1989 Apr; 7(2):97-101. PubMed ID: 2665354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.